Cargando…
Experimental models of demyelination and remyelination()
INTRODUCTION: Experimental animal models constitute a useful tool to deepen our knowledge of central nervous system disorders. In the case of multiple sclerosis, however, there is no such specific model able to provide an overview of the disease; multiple models covering the different pathophysiolog...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148713/ http://dx.doi.org/10.1016/j.nrleng.2019.03.007 |
_version_ | 1783520651608326144 |
---|---|
author | Torre-Fuentes, L. Moreno-Jiménez, L. Pytel, V. Matías-Guiu, J.A. Gómez-Pinedo, U. Matías-Guiu, J. |
author_facet | Torre-Fuentes, L. Moreno-Jiménez, L. Pytel, V. Matías-Guiu, J.A. Gómez-Pinedo, U. Matías-Guiu, J. |
author_sort | Torre-Fuentes, L. |
collection | PubMed |
description | INTRODUCTION: Experimental animal models constitute a useful tool to deepen our knowledge of central nervous system disorders. In the case of multiple sclerosis, however, there is no such specific model able to provide an overview of the disease; multiple models covering the different pathophysiological features of the disease are therefore necessary. DEVELOPMENT: We reviewed the different in vitro and in vivo experimental models used in multiple sclerosis research. Concerning in vitro models, we analysed cell cultures and slice models. As for in vivo models, we examined such models of autoimmunity and inflammation as experimental allergic encephalitis in different animals and virus-induced demyelinating diseases. Furthermore, we analysed models of demyelination and remyelination, including chemical lesions caused by cuprizone, lysolecithin, and ethidium bromide; zebrafish; and transgenic models. CONCLUSIONS: Experimental models provide a deeper understanding of the different pathogenic mechanisms involved in multiple sclerosis. Choosing one model or another depends on the specific aims of the study. |
format | Online Article Text |
id | pubmed-7148713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Sociedad Española de Neurología. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71487132020-04-13 Experimental models of demyelination and remyelination() Torre-Fuentes, L. Moreno-Jiménez, L. Pytel, V. Matías-Guiu, J.A. Gómez-Pinedo, U. Matías-Guiu, J. Neurología (English Edition) Article INTRODUCTION: Experimental animal models constitute a useful tool to deepen our knowledge of central nervous system disorders. In the case of multiple sclerosis, however, there is no such specific model able to provide an overview of the disease; multiple models covering the different pathophysiological features of the disease are therefore necessary. DEVELOPMENT: We reviewed the different in vitro and in vivo experimental models used in multiple sclerosis research. Concerning in vitro models, we analysed cell cultures and slice models. As for in vivo models, we examined such models of autoimmunity and inflammation as experimental allergic encephalitis in different animals and virus-induced demyelinating diseases. Furthermore, we analysed models of demyelination and remyelination, including chemical lesions caused by cuprizone, lysolecithin, and ethidium bromide; zebrafish; and transgenic models. CONCLUSIONS: Experimental models provide a deeper understanding of the different pathogenic mechanisms involved in multiple sclerosis. Choosing one model or another depends on the specific aims of the study. Sociedad Española de Neurología. Published by Elsevier España, S.L.U. 2020 2019-04-10 /pmc/articles/PMC7148713/ http://dx.doi.org/10.1016/j.nrleng.2019.03.007 Text en © 2017 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Torre-Fuentes, L. Moreno-Jiménez, L. Pytel, V. Matías-Guiu, J.A. Gómez-Pinedo, U. Matías-Guiu, J. Experimental models of demyelination and remyelination() |
title | Experimental models of demyelination and remyelination() |
title_full | Experimental models of demyelination and remyelination() |
title_fullStr | Experimental models of demyelination and remyelination() |
title_full_unstemmed | Experimental models of demyelination and remyelination() |
title_short | Experimental models of demyelination and remyelination() |
title_sort | experimental models of demyelination and remyelination() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148713/ http://dx.doi.org/10.1016/j.nrleng.2019.03.007 |
work_keys_str_mv | AT torrefuentesl experimentalmodelsofdemyelinationandremyelination AT morenojimenezl experimentalmodelsofdemyelinationandremyelination AT pytelv experimentalmodelsofdemyelinationandremyelination AT matiasguiuja experimentalmodelsofdemyelinationandremyelination AT gomezpinedou experimentalmodelsofdemyelinationandremyelination AT matiasguiuj experimentalmodelsofdemyelinationandremyelination |